New data on human macrophages polarization by Hymenolepis diminuta tapeworm-An in vitro study

Frontiers in Immunology

Volumn 8, Issue FEB, 2017, Pages

  Zawistowska Deniziak, Anna ^a   Basalaj, Katarzyna ^a   Strojny, Barbara ^b   Mlocicki, Daniel ^a,c  

^a W STEFA SKI INSTITUTE OF PARASITOLOGY   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cestoda; Host parasite interactions; Human; Hymenolepis diminuta; Immunology; Immunomodulation; Macrophages

Indexed keywords

CHAPERONIN 60; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEMATOPOIETIC CELL KINASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RANTES; STAT2 PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STIMULATION; CYTOKINE PRODUCTION; DNA MICROARRAY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION ASSAY; HUMAN; HYMENOLEPIS DIMINUTA; MACROPHAGE; MALE; NONHUMAN; POLARIZATION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

EID: 85014414666     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00148     Document Type: Article

References (92)

1. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 8(12):958-69. doi:10.1038/nri2448
2. Grinberg S, Hasko G, Wu D, Leibovich SJ. Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype. Am J Pathol (2009) 175(6):2439-53. doi:10.2353/ajpath.2009.090290
3. Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, Outram S, et al. The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling. Inflammation (2013) 36(4):921-31. doi:10.1007/s10753-013-9621-3
4. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 41(1):14-20. doi:10.1016/j.immuni.2014.06.008
5. Schultze JL, Freeman T, Hume DA, Latz E. A transcriptional perspective on human macrophage biology. Semin Immunol (2015) 27(1):44-50. doi:10.1016/j.smim.2015.02.001
6. Peon AN, Espinoza-Jimenez A, Terrazas LI. Immunoregulation by Taenia crassiceps and its antigens. Biomed Res Int (2013) 2013:498583. doi:10.1155/2013/498583
7. Baska P, Zawistowska-Deniziak A, Zdziarska AM, Wasyl K, Wisniewski M, Cywinska A, et al. Fasciola hepatica-the pilot study of in vitro assessing immune response against native and recombinant antigens of the fluke. Acta Parasitol (2013) 58(4):453-62. doi:10.2478/s11686-013-0163-5
8. Rehman ZU, Knight JS, Koolaard J, Simpson HV, Pernthaner A. Immunomodulatory effects of adult Haemonchus contortus excretory/secretory products on human monocyte-derived dendritic cells. Parasite Immunol (2015) 37(12):657-69. doi:10.1111/pim.12288
9. McKay DM. The immune response to and immunomodulation by Hymenolepis diminuta. Parasitology (2010) 137(3):385-94. doi:10.1017/S0031182009990886
10. Okada H, Kuhn C, Feillet H, Bach JF. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol (2010) 160(1):1-9. doi:10.1111/j.1365-2249.2010.04139.x
11. Wiria AE, Sartono E, Supali T, Yazdanbakhsh M. Helminth infections, type-2 immune response, and metabolic syndrome. PLoS Pathog (2014) 10(7):e1004140. doi:10.1371/journal.ppat.1004140
12. Weinstock JV, Elliott DE. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis (2009) 15(1):128-33. doi:10.1002/ibd.20633
13. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol (2003) 3(9):733-44. doi:10.1038/nri1183
14. Maizels RM. Parasitic helminth infections and the control of human allergic and autoimmune disorders. Clin Microbiol Infect (2016) 22(6):481-6. doi:10.1016/j.cmi.2016.04.024
15. Reyes JL, Fernando MR, Lopes F, Leung G, Mancini NL, Matisz CE, et al. IL-22 restrains tapeworm-mediated protection against experimental colitis via regulation of IL-25 expression. PLoS Pathog (2016) 12(4):e1005481. doi:10.1371/journal.ppat.1005481
16. Graepel R, Leung G, Wang A, Villemaire M, Jirik FR, Sharkey KA, et al. Murine autoimmune arthritis is exaggerated by infection with the rat tapeworm, Hymenolepis diminuta. Int J Parasitol (2013) 43(7):593-601. doi:10.1016/j.ijpara.2013.02.006
17. Johnston MJ, Wang A, Catarino ME, Ball L, Phan VC, MacDonald JA, et al. Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect Immun (2010) 78(3):1364-75. doi:10.1128/IAI.01349-08
18. Bien J, Salamatin R, Sulima A, Savijoki K, Bruce Conn D, Nareaho A, et al. Mass spectrometry analysis of the excretory-secretory (E-S) products of the model cestode Hymenolepis diminuta reveals their immunogenic properties and the presence of new E-S proteins in cestodes. Acta Parasitol (2016) 61(2):429-42. doi:10.1515/ap-2016-0058
19. Guigas B, Molofsky AB. A worm of one's own: how helminths modulate host adipose tissue function and metabolism. Trends Parasitol (2015) 31(9):435-41. doi:10.1016/j.pt.2015.04.008
20. Hussaarts L, Garcia-Tardon N, van Beek L, Heemskerk MM, Haeberlein S, van der Zon GC, et al. Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice. FASEB J (2015) 29(7):3027-39. doi:10.1096/fj.14-266239
21. Reyes JL, Lopes F, Leung G, Mancini NL, Matisz CE, Wang A, et al. Treatment with cestode parasite antigens results in recruitment of CCR2+ myeloid cells, the adoptive transfer of which ameliorates colitis. Infect Immun (2016) 84(12):3471-83. doi:10.1128/IAI.00681-16
22. Matisz CE, Leung G, Reyes JL, Wang A, Sharkey KA, McKay DM. Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice. Eur J Immunol (2015) 45(11):3126-39. doi:10.1002/eji.201545579
23. Lopes F, Reyes JL, Wang A, Leung G, McKay DM. Enteric epithelial cells support growth of Hymenolepis diminuta in vitro and trigger TH2-promoting events in a species-specific manner. Int J Parasitol (2015) 45(11):691-6. doi:10.1016/j.ijpara.2015.05.004
24. Reyes JL, Wang A, Fernando MR, Graepel R, Leung G, van Rooijen N, et al. Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages. J Immunol (2015) 194(1):364-78. doi:10.4049/jimmunol.1400738
25. Gao XX, Wang BX, Fei XF, Zhang J, Gong YJ, Minami M, et al. Effects of polysaccharides (FI0-c) from mycelium of Ganoderma tsugae on proinflammatory cytokine production by THP-1 cells and human PBMC (II). Acta Pharmacol Sin (2000) 21(12):1186-92.
26. Han XQ, Chung Lap Chan B, Dong CX, Yang YH, Ko CH, Gar-Lee Yue G, et al. Isolation, structure characterization, and immunomodulating activity of a hyperbranched polysaccharide from the fruiting bodies of Ganoderma sinense. J Agric Food Chem (2012) 60(17):4276-81. doi:10.1021/jf205056u
27. Schroecksnadel S, Jenny M, Fuchs D. Myelomonocytic THP-1 cells for in vitro testing of immunomodulatory properties of nanoparticles. J Biomed Nanotechnol (2011) 7(1):209-10. doi:10.1166/jbn.2011.1272
28. Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol (2014) 23(1):37-45. doi:10.1016/j.intimp.2014.08.002
29. Jain SK, Sahu R, Walker LA, Tekwani BL. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line. J Vis Exp (2012) 30(70):4054. doi:10.3791/4054
30. Gov L, Karimzadeh A, Ueno N, Lodoen MB. Human innate immunity to Toxoplasma gondii is mediated by host caspase-1 and ASC and parasite GRA15. MBio (2013) 4(4):e255-213. doi:10.1128/mBio.00255-13
31. Baska P, Wisniewski M, Krzyzowska M, Dlugosz E, Zygner W, Gorski P, et al. Molecular cloning and characterisation of in vitro immune response against astacin-like metalloprotease Ace-MTP-2 from Ancylostoma ceylanicum. Exp Parasitol (2013) 133(4):472-82. doi:10.1016/j.exppara.2013.01.006
32. Jaguin M, Houlbert N, Fardel O, Lecureur V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell Immunol (2013) 281(1):51-61. doi:10.1016/j.cellimm.2013.01.010
33. Maess MB, Sendelbach S, Lorkowski S. Selection of reliable reference genes during THP-1 monocyte differentiation into macrophages. BMC Mol Biol (2010) 11:90. doi:10.1186/1471-2199-11-90
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (2001) 25(4):402-8. doi:10.1006/meth.2001.1262
35. Kelly B, O'Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res (2015) 25(7):771-84. doi:10.1038/cr.2015.68
36. Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet (2012) 13(4):227-32. doi:10.1038/nrg3185
37. Xu L, Kitade H, Ni Y, Ota T. Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease. Biomolecules (2015) 5(3):1563-79. doi:10.3390/biom5031563
38. Standiford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol (1996) 59(1):24-8.
39. Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun (1998) 66(10):4690-5.
40. Hillyer P, Male D. Expression of chemokines on the surface of different human endothelia. Immunol Cell Biol (2005) 83(4):375-82. doi:10.1111/j.1440-1711.2005.01345.x
41. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest (1998) 101(8):1693-8. doi:10.1172/JCI1020
42. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol (2002) 3:7. doi:10.1186/1471-2172-3-7
43. Sullivan NL, EickhoffCS, Zhang X, Giddings OK, Lane TE, Hoft DF. Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation. J Immunol (2011) 187(3):1358-68. doi:10.4049/jimmunol.1100033
44. Mantovani A, Locati M, Polentarutti N, Vecchi A, Garlanda C. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. J Leukoc Biol (2004) 75(5):738-42. doi:10.1189/jlb.1003473
45. Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, et al. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. J Hepatol (2011) 54(3):422-31. doi:10.1016/j.jhep.2010.07.014
46. Bartel DP. microRNAs: target recognition and regulatory functions. Cell (2009) 136(2):215-33. doi:10.1016/j.cell.2009.01.002
47. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood (1994) 84(12):4008-27.
48. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 13(5):715-25. doi:10.1016/S1074-7613(00)00070-4
49. Teng MW, Bowman EP, McElwee JJ, Smyth MJ, Casanova JL, Cooper AM, et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med (2015) 21(7):719-29. doi:10.1038/nm.3895
50. Dixon KO, van der Kooij SW, Vignali DA, van Kooten C. Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members. Eur J Immunol (2015) 45(6):1736-47. doi:10.1002/eji.201445217
51. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol (2010) 11(12):1093-101. doi:10.1038/ni.1952
52. Muller WA. Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol (2011) 6:323-44. doi:10.1146/annurev-pathol-011110-130224
53. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, et al. The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 285(5425):221-7. doi:10.1126/science.285.5425.221
54. Bourdillon MC, Poston RN, Covacho C, Chignier E, Bricca G, McGregor JL. ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol (2000) 20(12):2630-5. doi:10.1161/01.ATV.20.12.2630
55. Bendjelloul F, Maly P, Mandys V, Jirkovska M, Prokesova L, Tuckova L, et al. Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis. Clin Exp Immunol (2000) 119(1):57-63. doi:10.1046/j.1365-2249.2000.01090.x
56. King PD, Sandberg ET, Selvakumar A, Fang P, Beaudet AL, Dupont B. Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing. J Immunol (1995) 154(11):6080-93.
57. Budnik A, Grewe M, Gyufko K, Krutmann J. Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hematol (1996) 24(2):352-9.
58. Whiteman SC, Bianco A, Knight RA, Spiteri MA. Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity. J Biol Chem (2003) 278(14):11954-61. doi:10.1074/jbc. M205329200
59. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol (1995) 60(1-2):9-15. doi:10.1016/0165-5728(95)00047-6
60. Wang HW, Babic AM, Mitchell HA, Liu K, Wagner DD. Elevated soluble ICAM-1 levels induce immune deficiency and increase adiposity in mice. FASEB J (2005) 19(8):1018-20. doi:10.1096/fj.04-3094fje
61. Aprahamian TR, Zhong X, Amir S, Binder CJ, Chiang LK, Al-Riyami L, et al. The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model. Int J Parasitol (2015) 45(4):203-7. doi:10.1016/j.ijpara.2014.12.006
62. Wolfs IM, Stoger JL, Goossens P, Pottgens C, Gijbels MJ, Wijnands E, et al. Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosis. FASEB J (2014) 28(1):288-99. doi:10.1096/fj.13-235911
63. Park YM. CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med (2014) 46:e99. doi:10.1038/emm.2014.38
64. An P, Freedman BI, Hanis CL, Chen YD, Weder AB, Schork NJ, et al. Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. Diabetes (2005) 54(3):909-14. doi:10.2337/diabetes.54.3.909
65. Love-Gregory L, Sherva R, Sun L, Wasson J, Schappe T, Doria A, et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet (2008) 17(11):1695-704. doi:10.1093/hmg/ddn060
66. Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Int J Obes (Lond) (2006) 30(6):877-83. doi:10.1038/sj.ijo.0803212
67. Goudriaan JR, Dahlmans VE, Teusink B, Ouwens DM, Febbraio M, Maassen JA, et al. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res (2003) 44(12):2270-7. doi:10.1194/jlr. M300143-JLR200
68. Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest (2002) 109(10):1381-9. doi:10.1172/JCI0214596
69. Koonen DP, Jacobs RL, Febbraio M, Young ME, Soltys CL, Ong H, et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes (2007) 56(12):2863-71. doi:10.2337/db07-0907
70. Harnett W, Harnett MM. Helminth-derived immunomodulators: can understanding the worm produce the pill? Nat Rev Immunol (2010) 10(4):278-84. doi:10.1038/nri2730
71. Klotz C, Ziegler T, Figueiredo AS, Rausch S, Hepworth MR, Obsivac N, et al. A helminth immunomodulator exploits host signaling events to regulate cytokine production in macrophages. PLoS Pathog (2011) 7(1):e1001248. doi:10.1371/journal.ppat.1001248
72. Al-Riyami L, Harnett W. Immunomodulatory properties of ES-62, a phosphorylcholine-containing glycoprotein secreted by Acanthocheilonema viteae. Endocr Metab Immune Disord Drug Targets (2012) 12(1):45-52. doi:10.2174/187153012799278893
73. Goodridge HS, Harnett W, Liew FY, Harnett MM. Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and-independent mechanisms and the implications for bioactive IL-12 and IL-23 responses. Immunology (2003) 109(3):415-25. doi:10.1046/j.1365-2567.2003.01689.x
74. Halleskog C, Mulder J, Dahlstrom J, Mackie K, Hortobagyi T, Tanila H, et al. WNT signaling in activated microglia is proinflammatory. Glia (2011) 59(1):119-31. doi:10.1002/glia.21081
75. Liu X, Lu R, Wu S, Sun J. Salmonella regulation of intestinal stem cells through the Wnt/beta-catenin pathway. FEBS Lett (2010) 584(5):911-6. doi:10.1016/j.febslet.2010.01.024
76. Neumann J, Schaale K, Farhat K, Endermann T, Ulmer AJ, Ehlers S, et al. Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J (2010) 24(11):4599-612. doi:10.1096/fj.10-160994
77. Umar S, Sarkar S, Wang Y, Singh P. Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin. J Biol Chem (2009) 284(33):22274-84. doi:10.1074/jbc. M109.020941
78. Sun J, Hobert ME, Duan Y, Rao AS, He TC, Chang EB, et al. Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2005) 289(1):G129-37. doi:10.1152/ajpgi.00515.2004
79. Salari S, Seibert T, Chen YX, Hu T, Shi C, Zhao X, et al. Extracellular HSP27 acts as a signaling molecule to activate NF-kappaB in macrophages. Cell Stress Chaperones (2013) 18(1):53-63. doi:10.1007/s12192-012-0356-0
80. Karin M, Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life (2005) 57(4-5):283-95. doi:10.1080/15216540500097111
81. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell (2006) 124(4):823-35. doi:10.1016/j.cell.2006.02.016
82. Cloutier A, Ear T, Borissevitch O, Larivee P, McDonald PP. Inflammatory cytokine expression is independent of the c-Jun N-terminal kinase/AP-1 signaling cascade in human neutrophils. J Immunol (2003) 171(7):3751-61. doi:10.4049/jimmunol.171.7.3751
83. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem (1999) 68:821-61. doi:10.1146/annurev.biochem.68.1.821
84. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol (2001) 2(8):599-609. doi:10.1038/35085068
85. Sakamoto KM, Frank DA. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res (2009) 15(8):2583-7. doi:10.1158/1078-0432.CCR-08-1137
86. Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol (2010) 185(11):6413-9. doi:10.4049/jimmunol.1001829
87. Westbom CM, Shukla A, MacPherson MB, Yasewicz EC, Miller JM, Beuschel SL, et al. CREB-induced inflammation is important for malignant mesothelioma growth. Am J Pathol (2014) 184(10):2816-27. doi:10.1016/j.ajpath.2014.06.008
88. Yi T, Lee DS, Jeon MS, Kwon SW, Song SU. Gene expression profile reveals that STAT2 is involved in the immunosuppressive function of human bone marrow-derived mesenchymal stem cells. Gene (2012) 497(2):131-9. doi:10.1016/j.gene.2012.01.073
89. Mounier R, Theret M, Arnold L, Cuvellier S, Bultot L, Goransson O, et al. AMPKalpha1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab (2013) 18(2):251-64. doi:10.1016/j.cmet.2013.06.017
90. Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, et al. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun (2013) 4:2834. doi:10.1038/ncomms3834
91. Ruckerl D, Jenkins SJ, Laqtom NN, Gallagher IJ, Sutherland TE, Duncan S, et al. Induction of IL-4Ralpha-dependent microRNAs identifies PI3K/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo. Blood (2012) 120(11):2307-16. doi:10.1182/blood-2012-02-408252
92. Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, et al. Akt-mTORC1 signaling regulates acly to integrate metabolic input to control of macrophage activation. Elife (2016) 5:e11612. doi:10.7554/eLife.11612